Abednego Moki Musyoki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Abednego Moki Musyoki has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
John M. Maingi
Department of Biochemistry, Microbiology and Biotechnology, School of Pure and Applied Sciences, Kenyatta University, Nairobi, Kenya
4 shared publicationsAnthony Karoki Maina
Department of Medical Laboratory Science, School of Health Sciences, Kenyatta University, Nairobi, Kenya
3 shared publicationsCecilia Ndungu
Department of Medical Laboratory, Murang’a County Referral Hospital, Murang’a, Kenya
3 shared publicationsJohn Maingi
Department of Biochemistry, Microbiology and Biotechnology, School of Pure and Applied Sciences, Kenyatta University, Nairobi, Kenya
3 shared publicationsKelvin Wangira Nyongesa
Department of Medical Research, Kenyatta National Hospital, Nairobi, Kenya
2 shared publications- Susan Githii
National Public Health Laboratory, Kenyatta National Hospital Grounds, Upperhill, Nairobi, Kenya
2 shared publications
Latest Publications
- Open Access
- 25 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Urinary tract infections caused by carbapenem-resistant Gram-negative bacteria among pregnant women attending antenatal care clinic at Murang’a County Referral Hospital, Kenya
Urinary tract infections (UTIs) continue to pose a significant health risk during pregnancy, with growing antimicrobial resistance making effective management increasingly challenging. Of more significance is the emergence of carbapenem-resistant (CR) bacteria, especially in resource-limited countries where diagnostic capabilities, treatment options, and comprehensive epidemiological data are inadequate. This study aimed to describe the prevalence, antimicrobial co-resistance patterns, and factors associated with UTIs caused by CR Gram-negative bacteria (GNB) among pregnant women at Murang’a County Referral Hospital in Kenya. A hospital-based cross-sectional study involving 365 pregnant women was conducted from May to October 2023. Participants were recruited through systematic random sampling; each underwent clinical evaluation. Demographic information was collected using a structured questionnaire, while clinical data were obtained from hospital records. Clean-catch midstream urine samples were processed in the hospital’s microbiology laboratory using standard microbiological techniques. The overall prevalence of UTIs was 25.5% (93/365; 95% CI: 21.01–29.95), with GNB (76.3%, 71/93) predominating. The prevalence of UTIs caused by CR-GNB and carbapenemase-producing (CP)-GNB was 4.93% (95% CI: 2.71–7.15) and 2.7% (95% CI: 1.07–4.41), respectively. Escherichia coli (E. coli) was the predominant pathogen overall (60.3%), and among CR-GNB (72.2%) and CP-GNB (60%) UTIs. More than half (10/18, 55.6%) of CR isolates co-produced extended β-lactamases (ESBLs) and carbapenemases. No colistin resistance was detected in carbapenem-resistant isolates. Co-resistance ranged from 38.5% to 92.3%, with the lowest resistance (≤ 46.2) to nitrofurantoin and aztreonam. High co-resistance (≥ 69%) was observed for most β-lactams, cephalosporins, aminoglycosides, and trimethoprim/sulfamethoxazole. 89% of CR isolates, including all CP-GNB, were multidrug-resistant. Multiple antibiotic resistance indices (0.67–0.93) were highest among CP isolates. Unmarried/single women were more likely to have UTIs caused by CP-GNB (adjusted odds ratio: 8.87; 95% CI: 1.57–50.01). Carbapenemase- and ESBL-co-producing GNB, predominated by E. coli, were present among pregnant women with UTIs. Unmarried/single status was the only variable significantly associated with CP-GNB UTIs in this study. Strengthening carbapenem stewardship and enhancing infection prevention practices are urgently needed to prevent further spread of resistant strains in the current context and beyond.
- 25 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessUrinary tract infections caused by carbapenem-resistant Gram-negative bacteria among pregnant women attending antenatal care clinic at Murang’a County Referral Hospital, Kenya
Urinary tract infections (UTIs) continue to pose a significant health risk during pregnancy, with growing antimicrobial resistance making effective management increasingly challenging. Of more significance is the emergence of carbapenem-resistant (CR) bacteria, especially in resource-limited countries where diagnostic capabilities, treatment options, and comprehensive epidemiological data are inadequate. This study aimed to describe the prevalence, antimicrobial co-resistance patterns, and factors associated with UTIs caused by CR Gram-negative bacteria (GNB) among pregnant women at Murang’a County Referral Hospital in Kenya. A hospital-based cross-sectional study involving 365 pregnant women was conducted from May to October 2023. Participants were recruited through systematic random sampling; each underwent clinical evaluation. Demographic information was collected using a structured questionnaire, while clinical data were obtained from hospital records. Clean-catch midstream urine samples were processed in the hospital’s microbiology laboratory using standard microbiological techniques. The overall prevalence of UTIs was 25.5% (93/365; 95% CI: 21.01–29.95), with GNB (76.3%, 71/93) predominating. The prevalence of UTIs caused by CR-GNB and carbapenemase-producing (CP)-GNB was 4.93% (95% CI: 2.71–7.15) and 2.7% (95% CI: 1.07–4.41), respectively. Escherichia coli (E. coli) was the predominant pathogen overall (60.3%), and among CR-GNB (72.2%) and CP-GNB (60%) UTIs. More than half (10/18, 55.6%) of CR isolates co-produced extended β-lactamases (ESBLs) and carbapenemases. No colistin resistance was detected in carbapenem-resistant isolates. Co-resistance ranged from 38.5% to 92.3%, with the lowest resistance (≤ 46.2) to nitrofurantoin and aztreonam. High co-resistance (≥ 69%) was observed for most β-lactams, cephalosporins, aminoglycosides, and trimethoprim/sulfamethoxazole. 89% of CR isolates, including all CP-GNB, were multidrug-resistant. Multiple antibiotic resistance indices (0.67–0.93) were highest among CP isolates. Unmarried/single women were more likely to have UTIs caused by CP-GNB (adjusted odds ratio: 8.87; 95% CI: 1.57–50.01). Carbapenemase- and ESBL-co-producing GNB, predominated by E. coli, were present among pregnant women with UTIs. Unmarried/single status was the only variable significantly associated with CP-GNB UTIs in this study. Strengthening carbapenem stewardship and enhancing infection prevention practices are urgently needed to prevent further spread of resistant strains in the current context and beyond.
- Open Access
- 22 April 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Candida urinary tract infections, antifungal susceptibility and factors associated with candiduria among pregnant women seeking antenatal care at Murang’a County Referral Hospital, Kenya
Candida urinary tract infections (UTIs) are a growing public health challenge in clinical practice. Immunologic and physiological changes that occur in pre
- 22 April 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Open AccessCandida urinary tract infections, antifungal susceptibility and factors associated with candiduria among pregnant women seeking antenatal care at Murang’a County Referral Hospital, Kenya
Candida urinary tract infections (UTIs) are a growing public health challenge in clinical practice. Immunologic and physiological changes that occur in pre
- Open Access
- 11 April 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Asymptomatic faecal carriage of multidrug-resistant and carbapenemase-producing Gram-negative bacteria among inpatients and outpatients in a Kenyan county referral hospital: a cross-sectional study
Carbapenem-resistant Gram-negative bacteria, particularly the carbapenemase producers, are increasingly a global public health concern. However, there is l
- 11 April 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessAsymptomatic faecal carriage of multidrug-resistant and carbapenemase-producing Gram-negative bacteria among inpatients and outpatients in a Kenyan county referral hospital: a cross-sectional study
Carbapenem-resistant Gram-negative bacteria, particularly the carbapenemase producers, are increasingly a global public health concern. However, there is l
- Open Access
- 10 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
High gastrointestinal carriage rates of extended-spectrum-β-lactamase-producing enterobacterales and associated factors among hospitalized and nonhospitalized children in Kenya
Gastrointestinal carriage of extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) presents a critical public health threat globally. However, in resource-constrained countries with poor sanitation, inadequate drinking water, and limited microbiology laboratories like Kenya, epidemiological data of these strains is limited. This study assessed the gastrointestinal carriage of ESBL-E and the risk factors for colonization among children (≤ 5 years) in the inpatient department (IPD) and outpatient department (OPD). This was a hospital-based cross-sectional study at Thika Level 5 Hospital, Kenya, from February to June 2023. In total, 540 participants (OPD: 270, IPD: 270) were recruited, using systematic random sampling and consecutive sampling in OPD and IPD, respectively. Children admitted for less than 48 h in the paediatrics ward and those with a prior history of hospitalization (≤ 3 months) in OPD were excluded. Demographic data were collected using a well-structured questionnaire. Following the standard microbiology methods, stool or rectal swab samples were cultured, with the identity and antimicrobial susceptibility of isolates elucidated by automated platforms. The overall ESBL-E gastrointestinal carriage rate was 35.4% (191/540), and was highest among outpatients at 40.4% (109/270). Isolates demonstrated co-resistance to aminoglycosides (43–52%), quinolones (52–62%), carbapenems (44–50%), and sulfonamides (92–97%). They were more susceptible to piperacillin/tazobactam (67–95%) and colistin (96–99%). Carbapenemase-producing Enterobacterales (CPE) co-carriage rate was 17.6% (16/91), with similar rates for inpatients (50%, 8/16) and outpatients (50%, 8/16). Escherichia coli was the predominant ESBL-E overall (82.2%, 157/191), among outpatients (83.5%, 91/109), and inpatients (80.5%, 66/82), and was also the main CPE (overall: 81.3%, 13/16; OPD: 75%, 6/8; IPD: 87.5%, 7/8). Independent predictors of colonization included child age (adjusted odds ratio (OR): 1.60, p = 0.045) and a history of antimicrobial use from retail pharmacies without a clinician’s prescription (adjusted OR: 0.18, p = 0.047). This study demonstrates a substantial burden of gastrointestinal carriage of ESBL-E and CPE co-carriage among children (≤ 5 years), with E. coli being the predominant organism. Age less than two years and a history of exposure to non-prescribed antimicrobials were independent factors for colonization. Efforts to limit exposure to contaminated environments and targeted antimicrobial stewardship initiatives are required to mitigate AMR in the current study setting.
- 10 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessHigh gastrointestinal carriage rates of extended-spectrum-β-lactamase-producing enterobacterales and associated factors among hospitalized and nonhospitalized children in Kenya
Gastrointestinal carriage of extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) presents a critical public health threat globally. However, in resource-constrained countries with poor sanitation, inadequate drinking water, and limited microbiology laboratories like Kenya, epidemiological data of these strains is limited. This study assessed the gastrointestinal carriage of ESBL-E and the risk factors for colonization among children (≤ 5 years) in the inpatient department (IPD) and outpatient department (OPD). This was a hospital-based cross-sectional study at Thika Level 5 Hospital, Kenya, from February to June 2023. In total, 540 participants (OPD: 270, IPD: 270) were recruited, using systematic random sampling and consecutive sampling in OPD and IPD, respectively. Children admitted for less than 48 h in the paediatrics ward and those with a prior history of hospitalization (≤ 3 months) in OPD were excluded. Demographic data were collected using a well-structured questionnaire. Following the standard microbiology methods, stool or rectal swab samples were cultured, with the identity and antimicrobial susceptibility of isolates elucidated by automated platforms. The overall ESBL-E gastrointestinal carriage rate was 35.4% (191/540), and was highest among outpatients at 40.4% (109/270). Isolates demonstrated co-resistance to aminoglycosides (43–52%), quinolones (52–62%), carbapenems (44–50%), and sulfonamides (92–97%). They were more susceptible to piperacillin/tazobactam (67–95%) and colistin (96–99%). Carbapenemase-producing Enterobacterales (CPE) co-carriage rate was 17.6% (16/91), with similar rates for inpatients (50%, 8/16) and outpatients (50%, 8/16). Escherichia coli was the predominant ESBL-E overall (82.2%, 157/191), among outpatients (83.5%, 91/109), and inpatients (80.5%, 66/82), and was also the main CPE (overall: 81.3%, 13/16; OPD: 75%, 6/8; IPD: 87.5%, 7/8). Independent predictors of colonization included child age (adjusted odds ratio (OR): 1.60, p = 0.045) and a history of antimicrobial use from retail pharmacies without a clinician’s prescription (adjusted OR: 0.18, p = 0.047). This study demonstrates a substantial burden of gastrointestinal carriage of ESBL-E and CPE co-carriage among children (≤ 5 years), with E. coli being the predominant organism. Age less than two years and a history of exposure to non-prescribed antimicrobials were independent factors for colonization. Efforts to limit exposure to contaminated environments and targeted antimicrobial stewardship initiatives are required to mitigate AMR in the current study setting.
- Open Access
- 14 November 2025
- Published by Springer Nature in BMC Microbiology
- Vol. 25 (1) , 743
Extended-spectrum β-lactamase and carbapenemase-producing bacteria urinary tract infections in adult HIV-positive outpatients at Embu County Referral Hospital, Kenya
Antimicrobial resistance (AMR) poses a significant threat to public health, with the Global Action Plan advocating, among others, for strengthening AMR knowledge and evidence base through surveillance and research and optimizing the use of antimicrobial medicines in human and animal health. However, due to inadequate healthcare infrastructure in many resource-constrained countries, epidemiological data to inform infection prevention interventions and guide antimicrobial policy guidelines in people living with HIV is limited. Here, we assessed the prevalence, antimicrobial resistance, and associated factors of bacterial urinary tract infections among adult HIV-positive outpatients in our study setting. This was a hospital-based cross-sectional study among adult HIV-positive outpatients at Embu County Referral Hospital, Kenya, from January to February 2023. We consecutively recruited 142 patients presenting with or without UTI symptoms and excluded those aged below 18. Demographic and clinical data were collected using a pretested questionnaire, and midstream-clean-catch urine samples were processed by standard microbiological methods. The overall prevalence of UTI was 9.9% (95% confidence interval (CI): 4.96–14.76% (14/142), with 6.3% symptomatic [95% CI: 2.33–10.35% (9/142)], 3.5% asymptomatic [95% CI: 0.49–6.55% (5/142)], and 4.2% recurrent [95% CI: 0.92–7.53% (6/142)] UTIs. Klebsiella pneumoniae was predominant overall (57.1%, 8/14), and in asymptomatic (80%, 4/5) and recurrent (66.7%, 4/6) UTIs. All the isolates were multidrug-resistant, with 36% (5/14) as meropenem-resistant and 14.3% (2/14) of carbapenem-resistant K. pneumoniae were colistin-resistant. E. coli isolates were susceptible to meropenem, amikacin, ciprofloxacin, and levofloxacin. The lowest resistance in K. pneumoniae was in amikacin (12.5%) and colistin (25%). Notably, 79% (11/14) and 35.7% (4/14) of the isolates were extended-spectrum β-lactamase (ESBL) and carbapenemase producers, respectively. Those with recurrent UTI were at higher odds of having UTI [adjusted odds ratio: 7.37, 95% CI: 1.93—28.07 (p = 0.003)]. Our findings highlight a high prevalence of bacterial urinary tract infections, including recurrent ones caused by ESBL-, carbapenemase-producing, and colistin-resistant bacteria among HIV-infected adults. A comprehensive One Health approach is urgently required to reduce the burden of AMR among HIV-infected people through promoting responsible antibiotic use via the existing regulatory frameworks and knowledge transfer, as well as AMR uninterrupted surveillance.
- 14 November 2025
- Published by Springer Nature in BMC Microbiology
- Vol. 25 (1) , 743
Open AccessExtended-spectrum β-lactamase and carbapenemase-producing bacteria urinary tract infections in adult HIV-positive outpatients at Embu County Referral Hospital, Kenya
Antimicrobial resistance (AMR) poses a significant threat to public health, with the Global Action Plan advocating, among others, for strengthening AMR knowledge and evidence base through surveillance and research and optimizing the use of antimicrobial medicines in human and animal health. However, due to inadequate healthcare infrastructure in many resource-constrained countries, epidemiological data to inform infection prevention interventions and guide antimicrobial policy guidelines in people living with HIV is limited. Here, we assessed the prevalence, antimicrobial resistance, and associated factors of bacterial urinary tract infections among adult HIV-positive outpatients in our study setting. This was a hospital-based cross-sectional study among adult HIV-positive outpatients at Embu County Referral Hospital, Kenya, from January to February 2023. We consecutively recruited 142 patients presenting with or without UTI symptoms and excluded those aged below 18. Demographic and clinical data were collected using a pretested questionnaire, and midstream-clean-catch urine samples were processed by standard microbiological methods. The overall prevalence of UTI was 9.9% (95% confidence interval (CI): 4.96–14.76% (14/142), with 6.3% symptomatic [95% CI: 2.33–10.35% (9/142)], 3.5% asymptomatic [95% CI: 0.49–6.55% (5/142)], and 4.2% recurrent [95% CI: 0.92–7.53% (6/142)] UTIs. Klebsiella pneumoniae was predominant overall (57.1%, 8/14), and in asymptomatic (80%, 4/5) and recurrent (66.7%, 4/6) UTIs. All the isolates were multidrug-resistant, with 36% (5/14) as meropenem-resistant and 14.3% (2/14) of carbapenem-resistant K. pneumoniae were colistin-resistant. E. coli isolates were susceptible to meropenem, amikacin, ciprofloxacin, and levofloxacin. The lowest resistance in K. pneumoniae was in amikacin (12.5%) and colistin (25%). Notably, 79% (11/14) and 35.7% (4/14) of the isolates were extended-spectrum β-lactamase (ESBL) and carbapenemase producers, respectively. Those with recurrent UTI were at higher odds of having UTI [adjusted odds ratio: 7.37, 95% CI: 1.93—28.07 (p = 0.003)]. Our findings highlight a high prevalence of bacterial urinary tract infections, including recurrent ones caused by ESBL-, carbapenemase-producing, and colistin-resistant bacteria among HIV-infected adults. A comprehensive One Health approach is urgently required to reduce the burden of AMR among HIV-infected people through promoting responsible antibiotic use via the existing regulatory frameworks and knowledge transfer, as well as AMR uninterrupted surveillance.
- Open Access
- 21 October 2025
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 14 (1) , 1-10
Asymptomatic faecal carriage of vancomycin-resistant Enterococci among inpatients and outpatients in a Kenyan hospital: a cross-sectional study
Vancomycin-resistant Enterococci (VRE) strains are a growing public health concern globally; however, epidemiological data to inform infection prevention and control interventions in line with antimicrobial resistance (AMR) global and national action plans in our study setting are limited. Here, we assessed VRE asymptomatic faecal carriage, AMR profiles and risk factors among inpatients and outpatients in a county referral hospital in Kenya. This was a cross-sectional study design among adult patients (≥ 18) at the Kiambu County Referral Hospital outpatient department (OPD) and patients in the inpatient department (IPD) from June to September 2022. A systematic random sampling technique was employed to recruit 155 participants from the OPD, excluding patients presenting with histories of diarrhoea, antibiotics use (≤ 48 h), and ≤ 90 days previous admission. In IPD, 155 patients admitted for ≥ 48 h, were consecutively enrolled, excluding diarrhoea cases. The participants’ sociodemographic and clinical data were collected using a structured questionnaire, with stool samples collected in sterile containers and transported in an icebox to Kenya Medical Research Institute, Nairobi, for analysis within 4–6 h, using standard and automated bacteriological methods. The overall faecal carriage of VRE was 5.2%, 95% confidence interval (CI): 2.98–8.25% (16/310), highest among the outpatients (3.9%; 12/310), 95% CI: 2.02–6.66%) where Enterococcus faecium predominated (overall: 62.5%, 10/16; IPD: 18.8%, 3/16; OPD: 43.8%, 7/16). VRE isolates were 100% resistant to erythromycin and tetracycline, with 31.3% (5/16) non-susceptible to teicoplanin, but remained sensitive to linezolid, tigecycline, and nitrofurantoin. Sixty-three per cent (62.5%, 10/16) of VRE isolates were multidrug-resistant, predominated by E. faecium (80%, 8/10). The multiple antibiotic resistance index (MARI) was > 0.2. The independent predictors of VRE carriage were female gender (aOR = 10.8, 95% CI 1.1-110.1, p = 0.045) and antibiotic dose completion behaviour (aOR = 0.122, 95% CI 0.0002-1.0, p = 0.046) among the outpatients. We report asymptomatic faecal carriage of VRE strains that are MDR predominately among outpatients, whereby females and patients with a history of not completing an antibiotic prescription were at increased risk of colonization. To inform infection prevention interventions, establishing the transmission mechanisms and sustained AMR surveillance are warranted to mitigate VRE spread in our study area.
- 21 October 2025
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 14 (1) , 1-10
Open AccessAsymptomatic faecal carriage of vancomycin-resistant Enterococci among inpatients and outpatients in a Kenyan hospital: a cross-sectional study
Vancomycin-resistant Enterococci (VRE) strains are a growing public health concern globally; however, epidemiological data to inform infection prevention and control interventions in line with antimicrobial resistance (AMR) global and national action plans in our study setting are limited. Here, we assessed VRE asymptomatic faecal carriage, AMR profiles and risk factors among inpatients and outpatients in a county referral hospital in Kenya. This was a cross-sectional study design among adult patients (≥ 18) at the Kiambu County Referral Hospital outpatient department (OPD) and patients in the inpatient department (IPD) from June to September 2022. A systematic random sampling technique was employed to recruit 155 participants from the OPD, excluding patients presenting with histories of diarrhoea, antibiotics use (≤ 48 h), and ≤ 90 days previous admission. In IPD, 155 patients admitted for ≥ 48 h, were consecutively enrolled, excluding diarrhoea cases. The participants’ sociodemographic and clinical data were collected using a structured questionnaire, with stool samples collected in sterile containers and transported in an icebox to Kenya Medical Research Institute, Nairobi, for analysis within 4–6 h, using standard and automated bacteriological methods. The overall faecal carriage of VRE was 5.2%, 95% confidence interval (CI): 2.98–8.25% (16/310), highest among the outpatients (3.9%; 12/310), 95% CI: 2.02–6.66%) where Enterococcus faecium predominated (overall: 62.5%, 10/16; IPD: 18.8%, 3/16; OPD: 43.8%, 7/16). VRE isolates were 100% resistant to erythromycin and tetracycline, with 31.3% (5/16) non-susceptible to teicoplanin, but remained sensitive to linezolid, tigecycline, and nitrofurantoin. Sixty-three per cent (62.5%, 10/16) of VRE isolates were multidrug-resistant, predominated by E. faecium (80%, 8/10). The multiple antibiotic resistance index (MARI) was > 0.2. The independent predictors of VRE carriage were female gender (aOR = 10.8, 95% CI 1.1-110.1, p = 0.045) and antibiotic dose completion behaviour (aOR = 0.122, 95% CI 0.0002-1.0, p = 0.046) among the outpatients. We report asymptomatic faecal carriage of VRE strains that are MDR predominately among outpatients, whereby females and patients with a history of not completing an antibiotic prescription were at increased risk of colonization. To inform infection prevention interventions, establishing the transmission mechanisms and sustained AMR surveillance are warranted to mitigate VRE spread in our study area.
- Open Access
- 28 December 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-10
Gastrointestinal carriage of carbapenemase-producing enterobacterales among inpatient and outpatient children in Kenya
Gastrointestinal carriage of antimicrobial-resistant bacteria, especially carbapenemase-producing Enterobacterales (CPE), presents a critical public health threat globally. However, in many resource-constrained countries, epidemiological data on CPE is limited. Here, we assessed gastrointestinal carriage and associated factors of CPE among inpatient and outpatient children (≤ 5 years). This hospital-based cross-sectional study was conducted at Thika Level 5 Hospital in Kenya from February to June 2023. In total, 540 participants were recruited from outpatient (270) and inpatient (270) children, excluding those admitted for < 48 h and outpatients with ≤ 3 months hospitalization history. Demographic data were collected using a questionnaire, and stool or swab samples were cultured following standard microbiology methods. Automated platforms were used for isolates identification and antimicrobial susceptibility testing. Gastrointestinal carriage rate of CPE was 9.6%, 95% confidence interval (CI): 6.39–13.79% (26/270) among the inpatients and 5.9%, 95% CI: 3.42–9.45% (16/270) among the outpatients. The carbapenemase-producing Enterobacterales were predominated by multidrug-resistant Escherichia coli from inpatients (22/22, 100%) and outpatients (8/10, 80%). The colonization rate was higher among inpatients who were presenting with chills (aOR = 10.57, p = 0.008). We report a high gastrointestinal carriage of CPE among children (≤ 5 years). Strict adherence to colonization screening, and antimicrobial stewardship policies are critical to control CPE dissemination in the current study area and beyond.
- 28 December 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-10
Open AccessGastrointestinal carriage of carbapenemase-producing enterobacterales among inpatient and outpatient children in Kenya
Gastrointestinal carriage of antimicrobial-resistant bacteria, especially carbapenemase-producing Enterobacterales (CPE), presents a critical public health threat globally. However, in many resource-constrained countries, epidemiological data on CPE is limited. Here, we assessed gastrointestinal carriage and associated factors of CPE among inpatient and outpatient children (≤ 5 years). This hospital-based cross-sectional study was conducted at Thika Level 5 Hospital in Kenya from February to June 2023. In total, 540 participants were recruited from outpatient (270) and inpatient (270) children, excluding those admitted for < 48 h and outpatients with ≤ 3 months hospitalization history. Demographic data were collected using a questionnaire, and stool or swab samples were cultured following standard microbiology methods. Automated platforms were used for isolates identification and antimicrobial susceptibility testing. Gastrointestinal carriage rate of CPE was 9.6%, 95% confidence interval (CI): 6.39–13.79% (26/270) among the inpatients and 5.9%, 95% CI: 3.42–9.45% (16/270) among the outpatients. The carbapenemase-producing Enterobacterales were predominated by multidrug-resistant Escherichia coli from inpatients (22/22, 100%) and outpatients (8/10, 80%). The colonization rate was higher among inpatients who were presenting with chills (aOR = 10.57, p = 0.008). We report a high gastrointestinal carriage of CPE among children (≤ 5 years). Strict adherence to colonization screening, and antimicrobial stewardship policies are critical to control CPE dissemination in the current study area and beyond.
- Open Access
- 16 August 2024
- Published by Springer Nature in Tropical Medicine and Health
- Vol. 52 (1) , 1-8
Prevalence and associated factors of TB and HIV coinfections among adult inmates with presumptive pulmonary TB in a Kenyan prison
Background: Tuberculosis (TB) is more than ten times higher in prisons compared to the general population, and HIV-infected persons are at increased risk of developing active TB and death. In the World Health Organization (WHO) African region, however, where the TB and HIV coinfections are highest, and prisons rarely factored in national disease surveillance, epidemiological data to inform TB control interventions in correctional facilities is limited. In this study, we assessed the prevalence of TB and HIV coinfections, as well as the factors associated with coinfections in our study setting. Methods: This was a prospective cross-sectional study among 157 adult (≥ 18 years) prisoners presenting with symptoms of pulmonary TB at Shimo La Tewa Prison, Kenya, between January and June 2023. The study excluded those with a history of anti-TB drugs use or on treatment follow-up and collected demographic and clinical characteristics data using a questionnaire. Sputum samples were collected and processed immediately using Xpert® MTB/RIF assay or stored at 4 °C for three (3) days in case of delay. Results: The overall prevalence of TB among inmates with presumptive pulmonary TB was 10.2%, 95% CI 6.37–16.91% (16/157), HIV 19.1%, 95% CI 13.73–25.97% (30/157). All the TB cases were positive for HIV (16/16, 100%), translating to TB/HIV coinfection of 10.2%, 95% CI 6.37–16.91% (16/157), and there was no rifampicin resistance. TB and HIV coinfection cases were found among underweight (100%, 16/16) prisoners. The independent factors associated with TB and HIV coinfections were education level (adjusted OR = 0.17, p = 0.007), smoking history (adjusted OR = 3.01, p = 0.009) and illegal drug use history (adjusted OR = 4.55, p = 0.044). Conclusion: We report a high prevalence of pulmonary TB and HIV coinfections among adult inmates with presumptive pulmonary TB in Kenya, with education level, smoking status, and illegal drug use as the independent factors associated with the coinfection. The authority should take measures to protect HIV-positive prisoners from TB, focusing on education, nutrition, smoking, and illegal drug use.
- 16 August 2024
- Published by Springer Nature in Tropical Medicine and Health
- Vol. 52 (1) , 1-8
Open AccessPrevalence and associated factors of TB and HIV coinfections among adult inmates with presumptive pulmonary TB in a Kenyan prison
Background: Tuberculosis (TB) is more than ten times higher in prisons compared to the general population, and HIV-infected persons are at increased risk of developing active TB and death. In the World Health Organization (WHO) African region, however, where the TB and HIV coinfections are highest, and prisons rarely factored in national disease surveillance, epidemiological data to inform TB control interventions in correctional facilities is limited. In this study, we assessed the prevalence of TB and HIV coinfections, as well as the factors associated with coinfections in our study setting. Methods: This was a prospective cross-sectional study among 157 adult (≥ 18 years) prisoners presenting with symptoms of pulmonary TB at Shimo La Tewa Prison, Kenya, between January and June 2023. The study excluded those with a history of anti-TB drugs use or on treatment follow-up and collected demographic and clinical characteristics data using a questionnaire. Sputum samples were collected and processed immediately using Xpert® MTB/RIF assay or stored at 4 °C for three (3) days in case of delay. Results: The overall prevalence of TB among inmates with presumptive pulmonary TB was 10.2%, 95% CI 6.37–16.91% (16/157), HIV 19.1%, 95% CI 13.73–25.97% (30/157). All the TB cases were positive for HIV (16/16, 100%), translating to TB/HIV coinfection of 10.2%, 95% CI 6.37–16.91% (16/157), and there was no rifampicin resistance. TB and HIV coinfection cases were found among underweight (100%, 16/16) prisoners. The independent factors associated with TB and HIV coinfections were education level (adjusted OR = 0.17, p = 0.007), smoking history (adjusted OR = 3.01, p = 0.009) and illegal drug use history (adjusted OR = 4.55, p = 0.044). Conclusion: We report a high prevalence of pulmonary TB and HIV coinfections among adult inmates with presumptive pulmonary TB in Kenya, with education level, smoking status, and illegal drug use as the independent factors associated with the coinfection. The authority should take measures to protect HIV-positive prisoners from TB, focusing on education, nutrition, smoking, and illegal drug use.
- Open Access
- 23 May 2024
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 24 (1) , 1-9
Carbapenem-resistant gram-negative bacterial infections and risk factors for acquisition in a Kenyan intensive care unit
Background: Carbapenem-resistant Gram-negative bacteria (CR-GNB) are a critical public health threat globally; however, there are inadequate surveillance data, especially in intensive care units (ICU), to inform infection prevention and control in many resource-constrained settings. Here, we assessed the prevalence of CR-GNB infections and risk factors for acquisition in a Kenyan ICU. Methods: A hospital-based cross-sectional study design was adopted, recruiting 162 patients clinically presenting with bacterial infection after 48 h of ICU admission, from January to October 2022 at the Nairobi West Hospital, Kenya. Demographics and clinical data were collected by case report form. The type of sample collected, including blood, tracheal aspirate, ascitic tap, urine, stool, and sputum depended on the patient’s clinical presentation and were transported to the hospital Microbiology laboratory in a cool box for processing within 2 h. The samples were analyzed by cultured and BD Phoenix system used for isolates’ identity and antimicrobial susceptibility. Results: CR-GNB infections prevalence was 25.9% (42/162), with Klebsiella pneumoniae (35.7%, 15/42) and Pseudomonas aeruginosa (26.2%, 11/42) predominating. All isolates were multidrug-resistant (MDR). P. aeruginosa and A. baumannii were 100% colistin-resistant, while K. pneumoniae (33.3%) was tigecycline-resistant. History of antibiotics (aOR = 3.40, p = 0.005) and nasogastric tube (NGT) use (aOR = 5.84, p = < 0.001) were the risk factors for infection. Conclusion: Our study highlights high MDR- and CR-GNB infections in ICU, with prior antibiotic exposure and NGT use as risk factors, and diminishing clinical value of colistin and tigecycline. In this study setting and beyond, strict implementation of antimicrobial stewardship programs and adherence to infection prevention and control through monitoring, evaluation and feedback are warranted to curb CR-GNB infections, especially among the risk groups.
- 23 May 2024
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 24 (1) , 1-9
Open AccessCarbapenem-resistant gram-negative bacterial infections and risk factors for acquisition in a Kenyan intensive care unit
Background: Carbapenem-resistant Gram-negative bacteria (CR-GNB) are a critical public health threat globally; however, there are inadequate surveillance data, especially in intensive care units (ICU), to inform infection prevention and control in many resource-constrained settings. Here, we assessed the prevalence of CR-GNB infections and risk factors for acquisition in a Kenyan ICU. Methods: A hospital-based cross-sectional study design was adopted, recruiting 162 patients clinically presenting with bacterial infection after 48 h of ICU admission, from January to October 2022 at the Nairobi West Hospital, Kenya. Demographics and clinical data were collected by case report form. The type of sample collected, including blood, tracheal aspirate, ascitic tap, urine, stool, and sputum depended on the patient’s clinical presentation and were transported to the hospital Microbiology laboratory in a cool box for processing within 2 h. The samples were analyzed by cultured and BD Phoenix system used for isolates’ identity and antimicrobial susceptibility. Results: CR-GNB infections prevalence was 25.9% (42/162), with Klebsiella pneumoniae (35.7%, 15/42) and Pseudomonas aeruginosa (26.2%, 11/42) predominating. All isolates were multidrug-resistant (MDR). P. aeruginosa and A. baumannii were 100% colistin-resistant, while K. pneumoniae (33.3%) was tigecycline-resistant. History of antibiotics (aOR = 3.40, p = 0.005) and nasogastric tube (NGT) use (aOR = 5.84, p = < 0.001) were the risk factors for infection. Conclusion: Our study highlights high MDR- and CR-GNB infections in ICU, with prior antibiotic exposure and NGT use as risk factors, and diminishing clinical value of colistin and tigecycline. In this study setting and beyond, strict implementation of antimicrobial stewardship programs and adherence to infection prevention and control through monitoring, evaluation and feedback are warranted to curb CR-GNB infections, especially among the risk groups.
- Open Access
- 25 October 2023
- Published by Elsevier in IJID Regions
- Vol. 9, 111-116
Carbapenem-resistant Acinetobacter baumannii infections: Antimicrobial resistance patterns and risk factors for acquisition in a Kenyan intensive care unit
- 25 October 2023
- Published by Elsevier in IJID Regions
- Vol. 9, 111-116
Open AccessCarbapenem-resistant Acinetobacter baumannii infections: Antimicrobial resistance patterns and risk factors for acquisition in a Kenyan intensive care unit